<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01636674</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-82</org_study_id>
    <nct_id>NCT01636674</nct_id>
  </id_info>
  <brief_title>18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer</brief_title>
  <acronym>COLOPET1</acronym>
  <official_title>Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Naestved Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Naestved Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are investigating the usefulness of 18F-Fluordeoxyglucose Positron Emission
      Tomography/ Computed Tomography (18F-FDG PET/CT) for staging and follow-up of colon cancer.
      Furthermore, the investigators combine 18F-FDG PET findings with clinical and
      histopathological features, circulating tumor cell (CTC) analyses, tumor gene expression and
      measurements of circulating cancer biomarkers sUPAR, TIMP-1 and CEA in order to predict tumor
      recurrence.

      The investigators hypothesis: The combination of functional imaging by 18F-FDG PET/CT and
      pre-existing and evolving molecular biomarkers will optimize tumor characterization, staging
      of disease and early detection of recurrence.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to recurrence</measure>
  </primary_outcome>
  <enrollment type="Actual">66</enrollment>
  <condition>Colon Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>18F-fluordeoxyglucose positron emission tomography/ computed tomography</intervention_name>
    <description>18F-fluordeoxyglucose positron emission tomography/ computed tomography for preoperative staging and post-operative follow-up</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical or histological diagnosis of malignant clonic neoplasm (distance of more than
             15 cm from anal ring)

          -  18 years of age or older

          -  written informed consent

        Exclusion Criteria:

          -  diabetes

          -  known malignant disease other than colon cancer

          -  known metastatic disease

          -  impairment of renal function

          -  allergy to CT contrast agents

          -  body weight of more than 150 kg

          -  claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bodil E Engelmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Naestved Hospital</affiliation>
  </overall_official>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2012</study_first_posted>
  <last_update_submitted>July 9, 2012</last_update_submitted>
  <last_update_submitted_qc>July 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Naestved Hospital</investigator_affiliation>
    <investigator_full_name>Bodil Elisabeth Engelmann</investigator_full_name>
    <investigator_title>MD, research fellow</investigator_title>
  </responsible_party>
  <keyword>positron emission tomography</keyword>
  <keyword>computed tomography</keyword>
  <keyword>fluordeoxyglucose</keyword>
  <keyword>colon cancer</keyword>
  <keyword>cancer</keyword>
  <keyword>staging</keyword>
  <keyword>imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

